Addressing Obesity: Exploring Emerging Strategies for Effective Management

Abstract

Obesity has emerged as a significant global health concern, with its prevalence escalating over recent decades. This surge has prompted the exploration of innovative pharmacotherapies, such as GLP-1 receptor agonists (GLP-1RA) and incretin-based treatments, to address associated health complications, including type 2 diabetes mellitus (T2DM), dyslipidemia, and hyperglycemia. These therapies have undergone rigorous clinical assessment for their effectiveness in mitigating obesity-related cardio-metabolic diseases and improving overall health outcomes. In this comprehensive review, we delve into the current landscape of obesity management, highlighting the pivotal role of emerging pharmaceutical interventions in combating the multifaceted challenges posed by this epidemic. By elucidating the latest advancements and therapeutic strategies, this review aims to provide insights into the ongoing efforts to tackle obesity and its associated health burdens on a global scale.